108 related articles for article (PubMed ID: 24147435)
1. Delineating the effects BRCA1 and BRCA2 loss of heterozygosity in pancreatic cancer progression.
Fam HK
Clin Genet; 2014 Jan; 85(1):18-20. PubMed ID: 24147435
[No Abstract] [Full Text] [Related]
2. High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions.
Lucas AL; Shakya R; Lipsyc MD; Mitchel EB; Kumar S; Hwang C; Deng L; Devoe C; Chabot JA; Szabolcs M; Ludwig T; Chung WK; Frucht H
Clin Cancer Res; 2013 Jul; 19(13):3396-403. PubMed ID: 23658460
[TBL] [Abstract][Full Text] [Related]
3. Germline BRCA1 mutations predispose to pancreatic adenocarcinoma.
Al-Sukhni W; Rothenmund H; Borgida AE; Zogopoulos G; O'Shea AM; Pollett A; Gallinger S
Hum Genet; 2008 Oct; 124(3):271-8. PubMed ID: 18762988
[TBL] [Abstract][Full Text] [Related]
4. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
[TBL] [Abstract][Full Text] [Related]
6. Identification of germline genetic mutations in patients with pancreatic cancer.
Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
[TBL] [Abstract][Full Text] [Related]
7. [Olaparib and pancreatic cancer: A challenging Lesson].
Louvet C; Samalin E; Michel P
Bull Cancer; 2019 Sep; 106(9):715-716. PubMed ID: 31399206
[No Abstract] [Full Text] [Related]
8. Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2.
Bell DW; Erban J; Sgroi DC; Haber DA
Cancer Res; 2002 May; 62(10):2741-3. PubMed ID: 12019146
[TBL] [Abstract][Full Text] [Related]
9. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer.
Stadler ZK; Salo-Mullen E; Patil SM; Pietanza MC; Vijai J; Saloustros E; Hansen NA; Kauff ND; Kurtz RC; Kelsen DP; Offit K; Robson ME
Cancer; 2012 Jan; 118(2):493-9. PubMed ID: 21598239
[TBL] [Abstract][Full Text] [Related]
11. No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer.
Campbell IG; Choong D; Chenevix-Trench G;
Breast Cancer Res; 2004; 6(4):R366-71. PubMed ID: 15217503
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity analysis in ductal lavage samples from BRCA1 and BRCA2 carriers: a cautionary tale.
Antill YC; Mitchell G; Johnson SA; Devereux L; Milner A; Phillips KA; Campbell IG
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1396-8. PubMed ID: 16835342
[TBL] [Abstract][Full Text] [Related]
13. Role of BRCA1 and BRCA2 mutations in pancreatic cancer.
Greer JB; Whitcomb DC
Gut; 2007 May; 56(5):601-5. PubMed ID: 16973716
[TBL] [Abstract][Full Text] [Related]
14. Inherited predisposition to pancreatic cancer.
Efthimiou E; Crnogorac-Jurcevic T; Lemoine NR; Brentnall TA
Gut; 2001 Feb; 48(2):143-7. PubMed ID: 11156628
[No Abstract] [Full Text] [Related]
15. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors.
Johannsdottir HK; Jonsson G; Johannesdottir G; Agnarsson BA; Eerola H; Arason A; Heikkila P; Egilsson V; Olsson H; Johannsson OT; Nevanlinna H; Borg A; Barkardottir RB
Int J Cancer; 2006 Sep; 119(5):1052-60. PubMed ID: 16570289
[TBL] [Abstract][Full Text] [Related]
17. Heterogenic loss of BRCA in breast cancer: the "two-hit" hypothesis takes a hit.
Meric-Bernstam F
Ann Surg Oncol; 2007 Sep; 14(9):2428-9. PubMed ID: 17406948
[No Abstract] [Full Text] [Related]
18. Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa.
Staff S; Isola JJ; Johannsson O; Borg A; Tanner MM
Br J Cancer; 2001 Oct; 85(8):1201-5. PubMed ID: 11710835
[TBL] [Abstract][Full Text] [Related]
19. Germ line Fanconi anemia complementation group C mutations and pancreatic cancer.
Couch FJ; Johnson MR; Rabe K; Boardman L; McWilliams R; de Andrade M; Petersen G
Cancer Res; 2005 Jan; 65(2):383-6. PubMed ID: 15695377
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation.
Willems AJ; Dawson SJ; Samaratunga H; De Luca A; Antill YC; Hopper JL; Thorne HJ;
Clin Cancer Res; 2008 May; 14(10):2953-61. PubMed ID: 18445692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
